| Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human … KC Conlon, E Lugli, HC Welles, SA Rosenberg, AT Fojo, JC Morris, ... Journal of clinical oncology 33 (1), 74-82, 2015 | 741 | 2015 |
| Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV M Roederer, BF Keele, SD Schmidt, RD Mason, HC Welles, W Fischer, ... Nature 505 (7484), 502-508, 2014 | 155 | 2014 |
| Immune-complexed adenovirus induce AIM2-mediated pyroptosis in human dendritic cells K Eichholz, T Bru, TTP Tran, P Fernandes, H Welles, FJD Mennechet, ... PLoS pathogens 12 (9), e1005871, 2016 | 80 | 2016 |
| Lack of Mycobacterium tuberculosis–specific interleukin‐17A–producing CD4+ T cells in active disease M Perreau, V Rozot, HC Welles, F Belluti‐Enders, S Vigano, M Maillard, ... European journal of immunology 43 (4), 939-948, 2013 | 76 | 2013 |
| Targeted isolation of antibodies directed against major sites of SIV Env vulnerability RD Mason, HC Welles, C Adams, BK Chakrabarti, J Gorman, T Zhou, ... PLoS Pathogens 12 (4), e1005537, 2016 | 66 | 2016 |
| DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa M Perreau, HC Welles, A Harari, O Hall, R Martin, M Maillard, G Dorta, ... Journal of virology 85 (19), 9854-9862, 2011 | 62 | 2011 |
| Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge HC Welles, MF Jennewein, RD Mason, S Narpala, L Wang, C Cheng, ... PLoS pathogens 14 (12), e1007395, 2018 | 49 | 2018 |
| The systemic anti-microbiota IgG repertoire can identify gut bacteria that translocate across gut barrier surfaces I Vujkovic-Cvijin, HC Welles, CWY Ha, L Huq, S Mistry, JM Brenchley, ... Science translational medicine 14 (658), eabl3927, 2022 | 41 | 2022 |
| Blocking α4β7 integrin binding to SIV does not improve virologic control N Iwamoto, RD Mason, K Song, J Gorman, HC Welles, J Arthos, C Cicala, ... Science 365 (6457), 1033-1036, 2019 | 32 | 2019 |
| The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes M Perreau, HC Welles, C Pellaton, B Gjoksi, L Potin, R Martin, A Harari, ... Journal of virology 86 (11), 6279-6285, 2012 | 28 | 2012 |
| Cryo-EM structures of prefusion SIV envelope trimer J Gorman, C Wang, RD Mason, AF Nazzari, HC Welles, T Zhou, ... Nature structural & molecular biology 29 (11), 1080-1091, 2022 | 11 | 2022 |
| Breakthrough virus neutralization resistance as a correlate of protection in a nonhuman primate heterologous simian immunodeficiency virus vaccine challenge study FH Lee, R Mason, H Welles, GH Learn, BF Keele, M Roederer, KJ Bar Journal of Virology 89 (24), 12388-12400, 2015 | 11 | 2015 |
| Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4 HC Welles, HAD King, L Nettey, N Cavett, J Gorman, T Zhou, Y Tsybovsky, ... PLoS Pathogens 18 (6), e1010574, 2022 | 7 | 2022 |
| Modulation of human memory T‐cell function by different antigen‐presenting cells M Perreau, HC Welles, A Harari, T Calandra, T Roger, G Pantaleo European journal of immunology 42 (3), 799-802, 2012 | 4 | 2012 |
| A high throughput lentivirus sieving assay identifies neutralization resistant Envelope sequences and predicts in vivo sieving N Iwamoto, R Mason, J Hu, A Ransier, H Welles, K Song, D Douek, ... Journal of immunological methods 464, 64-73, 2019 | 3 | 2019 |
| The Number of TLR9-Agonist Motifs in the Adenovirus Genome Correlates with Induction of DC Maturation by Adenovirus Immune Complexes M Perreau, HC Welles, C Pellaton, B Gjoksi, L Potin, R Martin J Virol 86 (11), 6279-85, 2012 | 2 | 2012 |
| Correction: Targeted isolation of antibodies directed against major sites of SIV Env vulnerability RD Mason, HC Welles, C Adams, BK Chakrabarti, J Gorman, T Zhou, ... Plos Pathogens 12 (5), e1005674, 2016 | 1 | 2016 |
| Results from the first-in-human phase I trials of recombinant human Interleukin 15 (rhIL-15) administered as a daily 30 minute intravenous infusion (IVB) for 12 consecutive … KC Conlon, E Lugli, SA Rosenberg, JC Morris, T Fleisher, H Welles, ... Cancer research 74 (19_Supplement), 2575-2575, 2014 | 1 | 2014 |
| Translocating bacteria in SIV infection are not stochastic and preferentially express cytosine methyltransferases JK Flynn, AM Ortiz, I Vujkovic-Cvijin, HC Welles, J Simpson, FMC Casta, ... Mucosal immunology 17 (5), 1089-1101, 2024 | | 2024 |
| Self-Assembling Nanoparticles GM Lynn, CMOB Garliss, AS Ishizuka, HC Welles US Patent App. 18/494,491, 2024 | | 2024 |